No headlines found.
Amwell Makes Grants to New Employees Under Inducement Plan
Globe Newswire (Mon, 4-Nov 4:05 PM ET)
Amwell Announces Results for Third Quarter 2024
Globe Newswire (Wed, 30-Oct 4:05 PM ET)
Amwell to participate in upcoming investor conferences
Globe Newswire (Mon, 28-Oct 7:00 AM ET)
Amwell announces new chief financial officer
Globe Newswire (Tue, 15-Oct 4:30 PM ET)
Amwell to report third quarter 2024 operating results
Globe Newswire (Tue, 15-Oct 7:05 AM ET)
Globe Newswire (Tue, 8-Oct 7:05 AM ET)
Amwell to Participate in Upcoming Investor Conferences
Globe Newswire (Thu, 22-Aug 4:05 PM ET)
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
American Well Class A trades on the NYSE stock market under the symbol AMWL.
As of November 12, 2024, AMWL stock price declined to $8.85 with 35,653 million shares trading.
AMWL has a beta of 1.17, meaning it tends to be more sensitive to market movements. AMWL has a correlation of 0.03 to the broad based SPY ETF.
AMWL has a market cap of $132.67 million. This is considered a Micro Cap stock.
Last quarter American Well Class A reported $61 million in Revenue and -$2.87 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.53.
In the last 3 years, AMWL traded as high as $175.60 and as low as $5.00.
The top ETF exchange traded funds that AMWL belongs to (by Net Assets): VTI, VXF, VHT, PRFZ, ITOT.
AMWL has underperformed the market in the last year with a price return of -60.5% while the SPY ETF gained +37.1%. AMWL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +4.9% and -10.9%, respectively, while the SPY returned +12.3% and +2.8%, respectively.
AMWL support price is $8.78 and resistance is $9.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMWL shares will trade within this expected range on the day.